Axtria Ignite 2025: Building on GenAI’s foundation with agen...
Hundreds of senior executives representing major pharma companies met last month at Axtria Ignite 2025 to discuss the future of agentic AI in the industry.
RFK Jr formally backs thimerosal ban in US vaccines
HHS Secretary Robert F Kennedy Jr has formally signed off on a recommendation to remove thimerosal from all flu vaccines in the US
Q2 clinical trials round-up: April to June 2025
The second quarter of 2025 has seen a surge of clinical trial activity across the pharmaceutical and biotech landscape.
European Commission approves 2nd IPCEI to sum of €403m
The European Commission has approved, under EU State aid rules, the second health-related IPCEI to support innovations in medical devices.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Revolutionising Clinical Trials: Evolution Summit 2025 Retur...
Marcus Evans is proud to announce the Evolution Summit September 2025, an exclusive, invitation-only event bringing together leading clinical trial executives, innovative suppliers
Welcome to the 3rd Spatial Biology for Drug Development Summ...
Transforming Research & Development with Faster, More Precise Spatial Insights
2nd Hit ID Summit
Why prioritise your hit discovery game? Finding the right chemical start points is crucial to help you save time and costs in the long run.
Unlocking the Potential of Targeting the Innate Immune Syste...
Ready to Catalyze the Next Wave of Inflammasome Therapies?
The Inaugural Market Access for CNS Therapeutics Summit Has ...
The only dedicated forum focused on tackling the unique commercial and reimbursement challenges facing treatments for neurodegeneration...